evidence demonstrating that an inadequate dose of HD causes adverse outcomes, the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend a target single-pool Kt/V (spKt/V) of 1.4 per session for patients receiving HD three times weekly, with a minimum spKt/V of 1.2 [1] . The guidelines also suggest a reduction in dose according to periodically measured residual renal function; in practice, however, few centers follow this recommendation.
On the other hand, peritoneal dialysis is typically initiated in an incremental manner. The residual renal function is measured at a minimum of every 2 months and the volume of peritoneal dialysis solution and frequency are increased as renal Kt/V declines [2] . A recent review article noted that the more rapid residual renal function decline and higher mortality in the early period of HD than in peritoneal dialysis may be due to the initiation pattern [3] .
Several studies have compared the clinical outcomes between the less frequent initiation of HD versus thrice-weekly HD administration in incident patients [4] [5] [6] [7] . According to the results, initiating HD less frequently benefits the preservation of residual renal function [4, 6] and does not reduce either quality of life (QOL) or patient survival [5, 7] . These data are promising with regard to improving the understanding of incremental HD; however, the limitations of these studies include small sample numbers and cross-sectional designs.
Here, in a large, nationwide prospective cohort, we compared clinical outcomes, including 24-h urine volume, QOL and survival, between a population undergoing HD initiation in an incremental manner and patients receiving HD three times weekly.
M A T E R I A L S A N D M E T H O D S

Study population
We enrolled patients !20 years of age who were initiated on maintenance HD for ESRD between August 2008 and September 2014 through a cohort study [Clinical Research Center for End-Stage Renal Disease (CRC for ESRD)] in South Korea. This investigation was a nationwide, multicenter, web-based, prospective cohort study of patients with ESRD and was designed to improve the survival and QOL of patients and create effective treatment guidelines (ClinicalTrials.gov; NCT00931970) [8] . Thirty-one hospitals participated in this cohort study and are listed in the Supplementary data.
We initially identified a total of 1528 incident HD patients and 927 of these patients, for whom essential information (including the number of HD sessions per week, demographic factors and laboratory data) was available for analysis were enrolled ( Figure 1 ). The patients were categorized into the thrice-weekly group or the incremental group according to whether the schedule of sessions at the initiation of HD was three times or one to two times per week, respectively.
All patients provided written informed consent before enrollment and the study was approved by the institutional review board at each center. All of the investigators conducted this study in accordance with the guidelines of the 2008 Declaration of Helsinki.
Demographic and clinical parameters
In the CRC for ESRD, both clinical and laboratory data were recorded by data coordinators who were trained to collect patient data through a combination of chart reviews and direct interviews using a standardized form. All laboratory tests were conducted at each center and urine was collected on a nondialysis day to obtain the 24-h urine volume. The estimated glomerular filtration rate (eGFR) was calculated using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations [9] . The modified Charlson Comorbidity Index (mCCI) was calculated for each patient at the initiation of dialysis. The mCCI, which was developed to predict 1-year mortality, has been validated in ESRD patients [10, 11] . The Subjective Global Assessment (SGA) is a nutritional assessment instrument that is widely utilized in clinical practice and was developed by Baker et al. [12] and standardized by Detsky et al. [13] . Based on a patient's history and physical examination, he/she is classified as follows: (i) normal/well-nourished, (ii) moderate/suspected of being malnourished or (iii) severely malnourished. The dialysis dose, as determined using the spKt/V, was calculated from the pre-and postdialysis urea concentrations based on the KDOQI guidelines [14] . The spKt/V and urea reduction rates were obtained at 3 months after the initiation of dialysis. Weekly Kt/V was defined as spKt/V multiplied by frequency per week. Weekly fluid ingestion was calculated as the sum of weekly ultrafiltration and 24-h urine volume multiplied by 7 days.
Outcomes
The primary outcome of this study was all-cause mortality. The secondary outcomes were mortality due to cardiovascular disease, health-related quality of life (HRQOL), depression and clinical outcomes at 12 months after dialysis initiation, including 24-h urine volume and SGA.
HRQOL and depression
The Kidney Disease Quality of Life Short Form (KDQOL-SF) version 1.3 has previously been used to evaluate HRQOL [15] . We utilized the Korean version of the KDQOL-SF, which was validated in Korean patients with ESRD [16] . Briefly, this tool consists of 80 items, including 36 items that provide a generic core supplemented with 43 kidney disease-targeted items and one overall health rating item. The KDQOL-SF and scoring manual can be found at http://www.rand.org/health/ surveys_tools/kdqol.html. In addition, the Korean version of the Beck's Depression Inventory (BDI) was used to evaluate depression in our patients. The BDI has been validated in various groups of patients and has been used to evaluate depression in patients undergoing dialysis [17] . The BDI consists of 21 selfreported items, each of which is rated on a scale of 0-3, with a possible score ranging from 0 to 63 [18] . Patients were requested to read and answer questions by themselves; the completion of both questionnaires usually required 20-30 min. Patients who completed two surveys at 3 months after beginning dialysis were included in this study, and some of these patients completed these surveys again at 1 year after dialysis initiation.
Statistical analysis
The propensity scores were estimated using logistic regression analyses adjusted for the patient's age, sex, primary renal disease, 24-h urine volume and levels of albumin and blood urea nitrogen (BUN) [19] . We matched the thrice-weekly and incremental groups at a 1:2 ratio using the nearest neighbor method with no replacement and a 0.2 caliper width. After matching, the two groups showed similar distributions of propensity scores, indicating that the differences in covariates between the two groups were minimized. We also assessed the standardized difference of each covariate, which was defined as the difference in the means or proportions of that covariate between the groups divided by a measure of the pooled standard deviation (SD) of the covariate. Small (<0.10) absolute values of a standardized difference indicated balance between the groups [20] . The characteristics of both groups were compared before and after propensity score matching.
Continuous variables are expressed as means and SDs and categorical variables are presented as frequencies with percentages. Continuous variables were compared using a t-test and categorical variables were compared using the chi-square test or Fisher's exact test. Survival was compared using a KaplanMeier curve with a log-rank test and the hazard ratio was calculated via Cox regression. All descriptive and survival analyses were conducted using SPSS software version 21.0 (SPSS, Chicago, IL, USA); R software version 2.14.2 (R Project for Statistical Computing, Vienna, Austria) was used for the propensity score matching. All statistical results were assessed using a two-tailed 95% confidence interval (CI) and P < 0.05 was considered statistically significant.
R E S U L T S
Baseline characteristics
Among 927 patients, 822 (88.7%) and 105 (11.3%) were included in the thrice-weekly and incremental groups, respectively ( Table 1 ). The incremental group consisted of older patients, and the rates of diabetes or hypertension as the primary renal disease were lower in this group than in the thriceweekly group. Systolic blood pressure was lower in the incremental group, but diastolic blood pressure and body mass index (BMI) were not different between the two groups.
Regarding nutritional status, 36.1% of the patients were considered to have moderate or severe malnutrition by the SGA in the thrice-weekly group, whereas only 24.5% of patients were considered to have moderate malnutrition in the incremental group. The albumin levels were also found to be higher in the incremental group.
The levels of renally excreted electrolytes (phosphorus and uric acid) were lower in the incremental group. In addition, the levels of BUN were significantly lower in the incremental group; however, the eGFR calculated using the CKD-EPI equation was not significantly different, with values of 7.3 6 6.5 and 7.5 6 3.4 mL/min/1.73 m 2 in the thrice-weekly and incremental groups, respectively.
The spKt/V and urea reduction rates were similar between the two groups. However, when the number of weekly HD sessions was taken into account, the weekly Kt/V values were 4.0 6 1.1 and 2.7 6 0.6 in the thrice-weekly and incremental
groups, respectively, which were significantly different. The ultrafiltration rate per session was significantly higher in the incremental group than in the thrice-weekly group before matching, but the rates were similar after matching. The weekly fluid ingestion was also similar between the two groups.
Propensity score matching of the cohort
After propensity score matching, 207 patients in the thriceweekly group were matched with 105 patients in the incremental group. The distributions of propensity scores before and after matching are illustrated in Figure 2 . Among the matched patients, all of the baseline characteristics, including age, sex, primary renal disease, systolic and diastolic blood pressure, BMI, mCCI, SGA, 24-h urine volume and the levels of hemoglobin, phosphorus, uric acid, albumin, BUN, creatinine, eGFR and cholesterol, were similar between the groups, whereas weekly Kt/V, which was not used as a propensity score matching variable, was different (Table 1) .
Survival analysis
During the median 15 months of follow-up, 154 patients from the total study population of 927 individuals died. Based on the Kaplan-Meier analysis, the all-cause mortality was not significantly different between the thrice-weekly and incremental groups before and after propensity score matching, as shown in Figure 3 [hazard ratio (HR) 1.03 (95% CI 0.62-1.71) before matching and HR 1.10 (95% CI 0.62-1.97) after matching]. When we divided the matched population into two groups according to the urine volume at baseline (!500 and <500 mL/ day), the survival of patients receiving incremental HD did not significantly differ from that of patients receiving thrice-weekly HD in either urine volume group [HR 0.93 (95% CI 0.47-1.86) for larger urine volume; HR 0.82 (95% CI 0.28-2.41) for smaller urine volume] (Figure 4) . Additionally, cardiovascular death did not differ between the two groups before or after propensity score matching (data not shown).
HRQOL and depression
KDQOL-SF and BDI data were available for 403 patients (49.0%) and 48 patients (45.7%) in the thrice-weekly and incremental groups, respectively. We compared the whole population and subpopulation who had completed the questionnaire at 3 months. Both populations showed similar characteristics The data are presented as mean 6 SD or as a n (%). PSM, propensity score matching; BP, blood pressure; BMI, body mass index; mCCI, modified Charlson comorbidity index; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate. Tables S1 and S2) . We compared the KDQOL-SF and BDI between the thriceweekly and incremental groups at 3 months following the initiation of dialysis (Table 2 ). Before and after propensity score matching, only the symptoms and problems domain was better in the incremental group. BDI was not significantly different between the two groups.
At 12 months after dialysis initiation, data on QOL questionnaires were available for only 252 patients (27.2%). This subpopulation was younger and showed a better nutritional status and higher phosphorus, BUN and creatinine levels than the original cohort before matching (Supplementary data, Table  S3 ); however, these parameters did not differ after matching (Supplementary data, Table S4 ). The KDQOL-SF and BDI scores at 12 months were similar between the groups with the exception of the cognitive functioning domain, which was better in the incremental group only before propensity score matching (Table 3) .
Patient characteristics at 12 months
At 12 months after the initiation of dialysis, $50% of patients were followed and the baseline characteristics of this subpopulation were similar to those of the original cohort (Supplementary data, Tables S5 and S6). The data from 436 patients in the thrice-weekly group and 57 patients in the incremental-start group were compared before and after propensity score matching (Table 4) . Among the 57 patients in the incremental group, 21 patients continued to receive twiceweekly dialysis at 12 months; however, 21 patients changed to thrice-weekly HD and 15 patients had no data regarding the number of sessions they underwent per week. In contrast with the baseline characteristics, the levels of uric acid and BUN were higher in the incremental group and the results were significant before and after propensity score matching.
The SGA nutritional index and levels of albumin were not different between the groups. There were no differences in the 24-h urine volume between the two groups before or after matching. Kaplan-Meier patient survival curves for the incremental versus thrice-weekly dialysis initiation for (A) urine volume !500 mL/ day and (B) <500 mL/day after propensity score matching. 
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In this study of a large prospective cohort, we determined the characteristics of the patients receiving incremental HD and, using propensity score matching, found that the survival of these patients was comparable to that of the patients receiving thrice-weekly HD. The short-and long-term HRQOL and BDI at 3 and 12 months after the initiation of dialysis were not significantly different between the two groups. Additionally, the The data are presented as mean 6 SD or as n (%). PSM, propensity score matching; BUN, blood urea nitrogen; SGA, subjective global assessment.
clinical data at 12 months after the initiation of dialysis, including the urine output and nutritional index, were also similar between the groups. In our nationwide prospective cohort, the majority of incident HD patients were initiated on thrice-weekly HD and only 11.3% of the patients were initiated on once-or twice-weekly HD. Older patients with preserved residual renal function tended to be started on once-or twice-weekly HD. These characteristics of the incremental-start group varied somewhat compared with those of previous studies. Regarding the age at initiation, studies from Thailand and China showed that patients who underwent twice-weekly treatments were younger than those who underwent thrice-weekly treatments [21, 22] . However, studies from the USA, Taiwan and Lithuania showed the opposite results, and these results were similar to those of the current study [7, 23, 24] . The decision to initiate once-, twice-or thrice-weekly HD in a patient is multifactorial and depends on the patient's clinical health status, the doctor's opinion, the patient's choice, the patient's economic status and the availability of medical resources. The socioeconomic background of the country is of particular importance. Most developed countries recommend thrice-weekly HD at initiation; developing countries with limited availability of medical resources inevitably proceed with less frequent dialysis sessions, and such limited schedules are used for $23.6% of patients in China [5] , 57.7% of patients in Thailand [21] and 74.8% of patients in Sudan [25] . In these developing countries, younger patients and patients with fewer comorbidities who are potentially more tolerant to volume and electrolyte imbalances are prescribed less frequent HD due to economic strain. In contrast, older patients and patients with more comorbidities appear to be initiated on HD in an incremental manner in developed countries.
The overall survival was not different between the thriceweekly and incremental groups before and after propensity score matching despite the different dialysis doses. Previously, reports from a single-center study in China showed that patients with twice-weekly HD experienced significantly decreased incidences of intradialytic hypotensive events and cardiovascular disease [26, 27] . However, patient survival has been repeatedly identified as similar between the thrice-weekly and incremental (or less frequent) HD groups in previous studies [7, 22, 23, 25, 28] . Regarding patient survival, Obi et al. [30] reported interesting results in a large cohort that showed higher mortality risk for the incremental regimen than for the thriceweekly regimen in patients with insufficient renal urea clearance ( 3.0 mL/min/1.73 m 2 ) or lower urine volume (<600 mL/day) [29] . These results suggested that patients with lower residual renal function were not suitable candidates for incremental regimens. We also conducted similar analyses according to the urine volume (!500 and <500 mL/day) but failed to find a significant difference. This result may be due to the relatively small sample size of patients, especially the small number of patients with a urine volume <500 mL/day (n ¼ 85).
Only one previous study has compared QOL between patients receiving twice-or thrice-weekly HD. Bieber et al. [5] analyzed 1286 incident HD patients in China and the HRQOL recorded at enrollment did not differ between the two groups. In the present study, HRQOL and BDI at 3 and 12 months after the initiation of dialysis were not significantly different between the thrice-weekly and incremental groups after propensity score matching, with the exception of one domain (symptoms and problems). The mean scores of all HRQOL domains at 3 and 12 months after initiation were higher in the incremental group, indicating better QOL than that in the thrice-weekly group, though these differences were not statistically significant. The mean BDI score was also lower in the incremental group, which indicated a less depressed mood. The results showed that there was no worsening of QOL due to underdialysis and that incremental dialysis may positively influence QOL.
Previously, Lin et al. [25] compared residual renal function at 18 months between 23 people receiving HD twice weekly and 51 people receiving treatment thrice weekly [24] . They reported that the twice-weekly group showed significantly better preservation of residual renal function, as indicated by residual creatinine clearance and urine volume. Two additional studies reported similar results [4, 6] . However, our study did not show the same results despite the larger sample size than those of the previous studies, which may have been due to the lower 12-month follow-up rate and missing patient data (up to 50%) in the present study. According to a previous large cohort study, the loss of residual renal function (as defined by a urine volume of <200 mL/24 h) occurred in 69% of incident HD patients after 12 months [30] . Therefore, the unknown 24-h urine volumes, which accounted for the majority of the missing values, might be included in the <500 mL/24 h category. The observation that the unknown rate appeared to be higher in the thriceweekly group may render the results insignificant. However, the possibility that incremental dialysis better preserves residual renal function is very promising and should be evaluated in a future large cohort.
In our study, the nutritional status at 12 months did not differ according to the frequency of dialysis. This result is similar to the results of a previous report that analyzed 142 people receiving HD in Thailand [21] . Between the twice-weekly and thrice-weekly groups, there was no difference in the nutritional parameters, such as BMI, waist circumference, body fat composition or laboratory data, including albumin and cholesterol.
There are some limitations to this study. First, approximately half of the participants were lost to follow-up at 12 months. Thus, due to possible selection bias, the clinical values at 12 months should be interpreted with caution. Second, the QOL questionnaires were completed by only 48.7% of the population at 3 months and by only 27.2% at 12 months. The subpopulation who completed the questionnaire showed several different baseline characteristics from those of the original cohort (especially for the data at 12 months), which implied selection bias. The KDQOL-SF is a highly comprehensive questionnaire for evaluating general and disease-specific QOL. Because the questionnaires take 20-30 min per patient to complete, patients often refuse to complete them. The results may have been different if the number of participants necessary to yield sufficient statistical power had been analyzed. Third, laboratory measurements were conducted at each center without using a uniform method. Lastly, the relatively small sample size resulted in a broad CI in survival analyses, which may not have excluded clinically important differences in survival. Despite these shortcomings, our study analyzed a large prospective cohort and raised the possibility that less frequent HD does not harm patients. Further randomized controlled trials of incremental versus thrice-weekly HD are needed to evaluate the clinical effect and set the standard format of incremental HD.
In conclusion, our prospective cohort study demonstrated that incremental or less frequent HD is not inferior to thriceweekly HD with respect to survival, QOL, nutritional status or the preservation of residual renal function. We suggest that incremental HD should be considered in selected patients.
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Supplementary data are available online at http://ndt.oxfordjournals.org.
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